What types of cancer is Entrectinib used to treat?
Entrectinib is primarily used to treat non-small cell lung cancer (NSCLC) that is ROS1-positive. Moreover, it is approved for the treatment of solid tumors that have a specific type of genetic alteration known as NTRK gene fusion, irrespective of the tumor's location in the body. This makes entrectinib a crucial option for the treatment of gene fusion-positive cancers.
